v3.19.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Aug. 03, 2019
Aug. 04, 2018
Cash flows from operating activities:    
Net income (loss) $ (105,781) $ 135,371
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 86,239 47,097
Share-based compensation 122,274 83,244
Amortization of acquired intangible assets 160,707 25,939
Amortization of inventory fair value adjustment associated with acquisition of Cavium 0 22,933
Amortization of deferred debt issuance costs and debt discounts 2,859 7,073
Restructuring related impairment charges 10,097 1,993
Other expense, net 2,016 3,631
Deferred income taxes 2,374 (21,414)
Changes in assets and liabilities:    
Accounts receivable 40,376 (48,749)
Inventories 8,674 6,866
Prepaid expenses and other assets (7,993) (19,504)
Accounts payable 22,497 (271)
Accrued liabilities and other non-current liabilities (80,117) (11,961)
Accrued employee compensation (25,266) (41,539)
Net cash provided by operating activities 238,956 190,709
Cash flows from investing activities:    
Purchases of available-for-sale securities 0 (14,956)
Sales of available-for-sale securities 0 623,896
Maturities of available-for-sale securities 0 187,985
Purchases of time deposits 0 (25,000)
Maturities of time deposits 0 150,000
Purchases of technology licenses (1,522) (1,263)
Purchases of property and equipment (42,193) (34,389)
Cash payment for acquisition of Cavium, net of cash and cash equivalents acquired 0 (2,649,465)
Other, net (389) (3,527)
Net cash used in investing activities (44,104) (1,766,719)
Cash flows from financing activities:    
Repurchases of common stock (64,272) 0
Proceeds from employee stock plans 81,314 44,580
Tax withholding paid on behalf of employees for net share settlement (61,642) (36,776)
Dividend payments to shareholders (79,356) (69,181)
Payments on technology license obligations (28,324) (29,478)
Proceeds from issuance of debt 0 1,892,605
Principal payments of debt (50,000) (606,128)
Payment of equity and debt financing costs 0 (9,435)
Other, net (1,486) 0
Net cash provided by (used in) financing activities (203,766) 1,186,187
Net decrease in cash and cash equivalents (8,914) (389,823)
Cash and cash equivalents at beginning of period 582,410 888,482
Cash and cash equivalents at end of period $ 573,496 $ 498,659